← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 28, 2014Last known activity
Jul 8, 2022
Timeline
2000s
- Jan 1, 2007
Singapore Institute for Clinical Sciences— Founded
Drugs by trial phase (9 distinct, 6 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT05579262Lead sponsorN/AJul 8, 2022
- NCT05579262Overall official - principal investigatorN/AJul 8, 2022
- NCT05579262Reponsible party - principal investigatorN/AJul 8, 2022
- NCT05046457Reponsible party - principal investigatorN/ASep 7, 2021
- NCT05046457Overall official - principal investigatorN/ASep 7, 2021
- NCT05046457Lead sponsorN/ASep 7, 2021
- NCT04545398CollaboratorN/ANov 1, 2020
- NCT02559102CollaboratorPhase 3Jul 1, 2015
- NCT02509988CollaboratorN/AJul 1, 2015
- NCT03281083CollaboratorPhase 2Mar 28, 2014
Details
- Founded
- SG Jan 1, 2007
- Last known activity
- Jul 8, 2022